Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) announced a private placement of 28th series unregistered coupon unguaranteed unsecured private convertible bonds for gross proceeds of KRW 10,200,000,000 on February 6, 2017. The transaction included participation from 24 investors, including existing investor Aju Savings Bank, Investment Arm for KRW 4,000,000,000, Shm Co.,Ltd for KRW 1,100,000,000, Sequoia Investments Ltd. for KRW 1,000,000,000, and 21 individual investors. The bonds will mature on February 6, 2020. The zero coupon bonds carry yield to maturity of 4%. The bonds can be 100% convertible into common shares at a fixed conversion price of KRW 4,102 per share from February 6, 2018 to January 6, 2020. The bonds were issued at par. The transaction has been approved by the board of directors of the company.